Modeling the host response to inhalation anthrax.

[1]  S. Shadomy,et al.  Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. , 2010, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[2]  G. Huffnagle,et al.  Transport of Bacillus anthracis from the lungs to the draining lymph nodes is a rapid process facilitated by CD11c+ cells. , 2010, Microbial pathogenesis.

[3]  Avner Friedman,et al.  Modeling the immune rheostat of macrophages in the lung in response to infection , 2009, Proceedings of the National Academy of Sciences.

[4]  K. Bradley,et al.  Anthrax Edema Toxin Induces Maturation of Dendritic Cells and Enhances Chemotaxis towards Macrophage Inflammatory Protein 3β , 2009, Infection and Immunity.

[5]  D. Kirschner,et al.  A methodology for performing global uncertainty and sensitivity analysis in systems biology. , 2008, Journal of theoretical biology.

[6]  Stephen S Morse,et al.  Inhalation anthrax: dose response and risk analysis. , 2008, Biosecurity and bioterrorism : biodefense strategy, practice, and science.

[7]  D. Wilkening.  Modeling the Incubation Period of Inhalational Anthrax , 2008, Medical decision making : an international journal of the Society for Medical Decision Making.

[8]  S. Welkos,et al.  Early interactions between fully virulent Bacillus anthracis and macrophages that influence the balance between spore clearance and development of a lethal infection. , 2008, Microbes and infection.

[9]  S. Shadomy,et al.  Conference Report on Public Health and Clinical Guidelines for Anthrax , 2008, Emerging infectious diseases.

[10]  B. Cookson,et al.  Anthrax lethal toxin and Salmonella elicit the common cell death pathway of caspase-1-dependent pyroptosis via distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.

[11]  E. Leffel,et al.  Pathology of Inhalational Anthrax Infection in the African Green Monkey , 2007, Veterinary pathology.

[12]  Steffen Jung,et al.  Lung Dendritic Cells Rapidly Mediate Anthrax Spore Entry through the Pulmonary Route1 , 2007, The Journal of Immunology.

[13]  S. Leppla,et al.  Anthrax Toxins Induce Shock in Rats by Depressed Cardiac Ventricular Function , 2007, PloS one.

[14]  Chien-Chang Lee,et al.  Comparison of Clinical Manifestations and Outcome of Community-Acquired Bloodstream Infections Among the Oldest Old, Elderly, and Adult Patients , 2007, Medicine.

[15]  F. Jatene,et al.  Mediastinal lymph node distribution, size and number: definitions based on an anatomical study. , 2007, Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia.

[16]  J. Rubin,et al.  A reduced mathematical model of the acute inflammatory response: I. Derivation of model and analysis of anti-inflammation. , 2006, Journal of theoretical biology.

[17]  G. Ruthel,et al.  Anthrax Lethal Toxin Impairs Innate Immune Functions of Alveolar Macrophages and Facilitates Bacillus anthracis Survival , 2006, Infection and Immunity.

[18]  C. Baldari,et al.  Anthrax toxins: A paradigm of bacterial immune suppression. , 2006, Trends in immunology.

[19]  K. Bradley,et al.  New insights into the functions of anthrax toxin , 2006, Expert Reviews in Molecular Medicine.

[20]  S. Welkos,et al.  Roles of Macrophages and Neutrophils in the Early Host Response to Bacillus anthracis Spores in a Mouse Model of Infection , 2006, Infection and Immunity.

[21]  A. Zychlinsky,et al.  Human Neutrophils Kill Bacillus anthracis , 2005, PLoS pathogens.

[22]  D. Stephens,et al.  Anthrax lethal toxin paralyzes neutrophil actin-based motility. , 2005, The Journal of infectious diseases.

[23]  K. Bradley,et al.  Anthrax toxin receptor 2 mediates Bacillus anthracis killing of macrophages following spore challenge , 2005, Cellular microbiology.

[24]  G. Clermont,et al.  THE ACUTE INFLAMMATORY RESPONSE IN DIVERSE SHOCK STATES , 2005, Shock.

[25]  G. Ruthel,et al.  Dendritic Cells Endocytose Bacillus anthracis Spores: Implications for Anthrax Pathogenesis 1 , 2005, The Journal of Immunology.

[26]  G. Clermont,et al.  In silico design of clinical trials: A method coming of age , 2004, Critical care medicine.

[27]  S. Welkos,et al.  The use of a model of in vivo macrophage depletion to study the role of macrophages during infection with Bacillus anthracis spores. , 2004, Microbial pathogenesis.

[28]  F. DeLeo,et al.  Modulation of phagocyte apoptosis by bacterial pathogens , 2004, Apoptosis.

[29]  Nancy Connell,et al.  Airborne Infection with Bacillus anthracis—from Mills to Mail , 2004, Emerging infectious diseases.

[30]  G. Ruthel,et al.  Time-lapse confocal imaging of development of Bacillus anthracis in macrophages. , 2004, The Journal of infectious diseases.

[31]  Jay Wells,et al.  Systemic cytokine response in murine anthrax , 2004, Cellular microbiology.

[32]  A. Prince.  The host response to anthrax lethal toxin: unexpected observations. , 2003, The Journal of clinical investigation.

[33]  T. Popović,et al.  Pathology and pathogenesis of bioterrorism-related inhalational anthrax. , 2003, The American journal of pathology.

[34]  J. Estep,et al.  Pathology of Inhalation Anthrax in Cynomolgus Monkeys (Macaca fascicularis) , 2003, Laboratory Investigation.

[35]  G. F. Webb,et al.  A silent bomb: The risk of anthrax as a weapon of mass destruction , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[36]  David L. Craft,et al.  Emergency response to an anthrax attack , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[37]  J. Kiel,et al.  Delayed treatment with doxycycline has limited effect on anthrax infection in BLK57/B6 mice. , 2002, Biochemical and biophysical research communications.

[38]  Rafael Villasmil,et al.  Effect of Bacillus anthracis lethal toxin on human peripheral blood mononuclear cells , 2002, FEBS letters.

[39]  C. Guidi‐Rontani.  The alveolar macrophage: the Trojan horse of Bacillus anthracis. , 2002, Trends in microbiology.

[40]  Glenn F Webb,et al.  Mailborne transmission of anthrax: Modeling and implications , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[41]  Charles L. Bailey,et al.  Lethal toxin of Bacillus anthracis causes apoptosis of macrophages. , 2002, Biochemical and biophysical research communications.

[42]  M. Swartz.  Recognition and management of anthrax--an update. , 2001, The New England journal of medicine.

[43]  S. Bavari,et al.  Macrophage-Derived Cell Lines Do Not Express Proinflammatory Cytokines after Exposure to Bacillus anthracis Lethal Toxin , 2001, Infection and Immunity.

[44]  T. Koehler,et al.  Early Bacillus anthracis–macrophage interactions: intracellular survival and escape , 2000 .

[45]  Cesare Montecucco,et al.  Anthrax lethal factor cleaves MKK3 in macrophages and inhibits the LPS/IFNγ‐induced release of NO and TNFα , 1999 .

[46]  P. Hanna,et al.  Understanding Bacillus anthracis pathogenesis. , 1999, Trends in microbiology.

[47]  M. Mock,et al.  Germination of Bacillus anthracis spores within alveolar macrophages , 1999, Molecular microbiology.

[48]  C. Dietrich,et al.  Mediastinal lymph nodes demonstrated by mediastinal sonography: Activity marker in patients with cystic fibrosis , 1999, Journal of clinical ultrasound : JCU.

[49]  M. Hugh-jones,et al.  The Sverdlovsk anthrax outbreak of 1979. , 1994, Science.

[50]  B. Bloom,et al.  Role of Macrophage Oxidative Burst in the Action of Anthrax Lethal Toxin , 1994, Molecular medicine.

[51]  C. Winterbourn,et al.  A single assay for measuring the rates of phagocytosis and bacterial killing by neutrophils , 1994, Journal of leukocyte biology.

[52]  D. Acosta,et al.  On the role of macrophages in anthrax. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[53]  J. Ezzell,et al.  Postexposure prophylaxis against experimental inhalation anthrax. , 1993, The Journal of infectious diseases.

[54]  G. Wright,et al.  Anthrax toxin blocks priming of neutrophils by lipopolysaccharide and by muramyl dipeptide , 1986, The Journal of experimental medicine.

[55]  J. Ezzell,et al.  Effects of anthrax toxin components on human neutrophils , 1985, Infection and immunity.

[56]  B. D. Hahn,et al.  A mathematical model of an anthrax epizoötic in the Kruger National Park , 1981 .

[57]  J. M. Ross.  The pathogenesis of anthrax following the administration of spores by the respiratory route , 1957 .

[58]  S. Popov.  New Candidate Anthrax Pathogenic Factors , 2008 .

[59]  P. Hanna.  Anthrax pathogenesis and host response. , 1998, Current topics in microbiology and immunology.

[60]  J. Dirckx.  Virgil on anthrax. , 1981, The American Journal of dermatopathology.